256 related articles for article (PubMed ID: 20387148)
21. Selective gene silencing by viral delivery of short hairpin RNA.
Sliva K; Schnierle BS
Virol J; 2010 Sep; 7():248. PubMed ID: 20858246
[TBL] [Abstract][Full Text] [Related]
22. Guidelines for the optimal design of miRNA-based shRNAs.
Bofill-De Ros X; Gu S
Methods; 2016 Jul; 103():157-66. PubMed ID: 27083402
[TBL] [Abstract][Full Text] [Related]
23. DNA vector-based RNA interference to study gene function in cancer.
Stovall DB; Wan M; Zhang Q; Dubey P; Sui G
J Vis Exp; 2012 Jun; (64):e4129. PubMed ID: 22710444
[TBL] [Abstract][Full Text] [Related]
24. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.
Fire A; Xu S; Montgomery MK; Kostas SA; Driver SE; Mello CC
Nature; 1998 Feb; 391(6669):806-11. PubMed ID: 9486653
[TBL] [Abstract][Full Text] [Related]
25. RNA Interference to Knock Down Gene Expression.
Han H
Methods Mol Biol; 2018; 1706():293-302. PubMed ID: 29423805
[TBL] [Abstract][Full Text] [Related]
26. Retrovirus and lentivirus vector design and methods of cell conditioning.
Cooray S; Howe SJ; Thrasher AJ
Methods Enzymol; 2012; 507():29-57. PubMed ID: 22365768
[TBL] [Abstract][Full Text] [Related]
27. Gene knockdown in the mouse through RNAi.
Kleinhammer A; Wurst W; Kühn R
Methods Enzymol; 2010; 477():387-414. PubMed ID: 20699152
[TBL] [Abstract][Full Text] [Related]
28. CRISPR genome engineering and viral gene delivery: a case of mutual attraction.
Schmidt F; Grimm D
Biotechnol J; 2015 Feb; 10(2):258-72. PubMed ID: 25663455
[TBL] [Abstract][Full Text] [Related]
29. Mitochondria and cancer: a growing role in apoptosis, cancer cell metabolism and dedifferentiation.
Scatena R
Adv Exp Med Biol; 2012; 942():287-308. PubMed ID: 22399428
[TBL] [Abstract][Full Text] [Related]
30. Of mice and men: human RNA polymerase III promoter U6 is more efficient than its murine homologue for shRNA expression from a lentiviral vector in both human and murine progenitor cells.
Roelz R; Pilz IH; Mutschler M; Pahl HL
Exp Hematol; 2010 Sep; 38(9):792-7. PubMed ID: 20685233
[TBL] [Abstract][Full Text] [Related]
31. Robust, reversible gene knockdown using a single lentiviral short hairpin RNA vector.
Brown CY; Sadlon T; Gargett T; Melville E; Zhang R; Drabsch Y; Ling M; Strathdee CA; Gonda TJ; Barry SC
Hum Gene Ther; 2010 Aug; 21(8):1005-17. PubMed ID: 20615123
[TBL] [Abstract][Full Text] [Related]
32. Journey of siRNA: Clinical Developments and Targeted Delivery.
Nikam RR; Gore KR
Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585
[TBL] [Abstract][Full Text] [Related]
33. The recent progresses in shRNA-nanoparticle conjugate as a therapeutic approach.
Acharya R
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109928. PubMed ID: 31500065
[TBL] [Abstract][Full Text] [Related]
34. shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy.
Zhang J; Ding M; Xu K; Mao L; Zheng J
Oncotarget; 2016 May; 7(20):29824-34. PubMed ID: 26980708
[TBL] [Abstract][Full Text] [Related]
35. Safety of antisense oligonucleotide and siRNA-based therapeutics.
Chi X; Gatti P; Papoian T
Drug Discov Today; 2017 May; 22(5):823-833. PubMed ID: 28159625
[TBL] [Abstract][Full Text] [Related]
36. RNA-Targeted Therapeutics.
Crooke ST; Witztum JL; Bennett CF; Baker BF
Cell Metab; 2018 Apr; 27(4):714-739. PubMed ID: 29617640
[TBL] [Abstract][Full Text] [Related]
37. shRNA-mediated silencing of hTERT suppresses proliferation and promotes apoptosis in osteosarcoma cells.
Chen P; Gu WL; Gong MZ; Wang J; Li DQ
Cancer Gene Ther; 2017 Aug; 24(8):325-332. PubMed ID: 28799566
[TBL] [Abstract][Full Text] [Related]
38. Puromycin-resistant lentiviral control shRNA vector, pLKO.1 induces unexpected cellular differentiation of P19 embryonic stem cells.
Kanungo J
Biochem Biophys Res Commun; 2017 Apr; 486(2):481-485. PubMed ID: 28322785
[TBL] [Abstract][Full Text] [Related]
39. Creating an miR30-based shRNA vector.
Chang K; Marran K; Valentine A; Hannon GJ
Cold Spring Harb Protoc; 2013 Jul; 2013(7):631-5. PubMed ID: 23818675
[TBL] [Abstract][Full Text] [Related]
40. Engineering Periodic shRNA for Enhanced Silencing Efficacy.
Wu C; Shopsowitz KE; Hammond PT
Mol Ther; 2016 Jun; 24(6):1070-1077. PubMed ID: 27053374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
